Skip to content

Effect of strawberry powder on diabetes complications

The effects of freeze - dried strawberry powder on glucose and lipid profile, malondialdehyde (MDA), hs-CRP and serum total antioxidant capacity in type 2 diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110117765N1
Enrollment
40
Registered
2012-08-02
Start date
2011-04-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None-insulin dependant diabetese mellistus. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention Group: 2 cups of strawberry beverage containing 50 gr of freeze dried strawberry daily for 6 weeks. Intervention 2: Control Group: 2 cups of Placebo beverage, containing
Treatment - Drugs
Placebo
Intervention Group: 2 cups of strawberry beverage containing 50 gr of freeze dried strawberry daily for 6 weeks
Control Group: 2 cups of Placebo beverage, containing 32 gr of placebo powder ( containing 24 g lactose and 8 g pectin ), daily for 6 weeks

Sponsors

Ahvaz Joundishapour University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having type 2 diabetes; 30 to 60 years old; LDL level more than 100 mg/Dl. Exclusion criteria: Having renal or hepatic failure; cardiovascular disease; thyroid disorders; lactose intolerance; treatment with insulin; taking corticosteroides, NSAIDS, cholesterol lowering drugs, multivitamin-mineral and fiber supplements; BMI more than 35 Kg/m2; smoking; pregnancy and lactation; use of multivitamin-mineral and fiber and antioxidant supplements 3 weeks prior to the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting Blood Sugar. Timepoint: baseline and after 6 weeks. Method of measurement: spectrophotometry.;Hemoglobin A1c. Timepoint: baseline and after 6 weeks. Method of measurement: Chromatography.;Total Cholesterol. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Triglyceride. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;LDL. Timepoint: Baseline and after 6 weeks. Method of measurement: Friedewald Formula.;HDL. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Malondialdehyde. Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;Total Antioxidant Capacity (TAC). Timepoint: Baseline and after 6 weeks. Method of measurement: Spectrophotometry.;HsCRP. Timepoint: Baseline and after 6 weeks. Method of measurement: Immunotorbidometry.

Secondary

MeasureTime frame
Dietary Factors. Timepoint: Baseline and after 6 weeks. Method of measurement: 3-day 24h dietary recalls.;Body Mass Index. Timepoint: Baseline and after 6 weeks. Method of measurement: Formula.;Blood Pressure. Timepoint: Baseline and after 6 weeks. Method of measurement: Sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Reza Amani

Para medicine Faculty, Ahvaz Joundishapour University of Medical Science

rezaamani@hotmail.com, sm.yaghmur@gmail.com+98 61 1373 8319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026